Atlas Trials

Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma

Clinical trial NCT05276167 · UNKNOWN

Trial details

NCT number
NCT05276167
Sponsor
Henan Cancer Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaPerfusion; ComplicationsIntraoperative Complications
Start date
2022-06-06
Primary completion
2024-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.